Multi-voxel Magnetic Resonance Spectroscopy of Cerebral Metabolites in Healthy Adults at 3 Tesla

Academic Radiology

Volumn 16, Issue 12, 2009, Pages 1493-1501

  Doelken, Marc Thorsten ^a   Mennecke, Angelika ^a   Stadlbauer, Andreas ^a   Kloska, Stefan ^a   Struffert, Tobias ^a   Engelhorn, Tobias ^a   Thuerauf, Norbert ^a   Doerfler, Arnd ^a   Stefan, Hermann ^a   Hammen, Thilo ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

3 telsa MRI; healthy adults; MRS; Spectroscopy

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BASAL GANGLION; BRAIN REGION; CONTROLLED STUDY; EPILEPSY; FEMALE; FRONTAL LOBE; GRAY MATTER; HIPPOCAMPUS; HUMAN; INSULA; LEFT HEMISPHERE; MALE; MENTAL DISEASE; METABOLITE; NORMAL HUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RIGHT HEMISPHERE; WHITE MATTER;

ADULT; BRAIN; CHOLINE; CREATINE; GLUTAMINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; REFERENCE VALUES; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 70350468883     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.07.025     Document Type: Article

References (50)

1. Castillo M., Kwock L., and Mukherji S.K. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 17 (1996) 1-15
2. Desseilles M., Ng-Vu T., Schabus M., et al. Neuroimaging insights into the pathophysiology of sleep disorders. Sleep 31 (2008) 777-794
3. Fayed N., Davila J., Oliveros A., et al. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. Acad Radiol 15 (2008) 1089-1098
4. Fojtikova D., Brazdil M., Horky J., et al. Magnetic resonance spectroscopy of the thalamus in patients with typical absence epilepsy. Seizure 15 (2006) 533-540
5. Helms G., Ciumas C., Kyaga S., et al. Increased thalamus levels of glutamate and glutamine (Glx) in patients with idiopathic generalised epilepsy. J Neurol Neurosurg Psychiatry 77 (2006) 489-494
6. Lenkinski R.E. Dementias and neuroimaging. Acad Radiol 15 (2008) 1087-1088
7. Lin K, Carrete JH, Lin J, et al. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy. Epilepsia. In press.
8. Savic I., Osterman Y., and Helms G. MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies. Neuroimage 21 (2004) 163-172
9. Safriel Y., Pol-Rodriguez M., Novotny E.J., et al. Reference values for long echo time MR spectroscopy in healthy adults. AJNR Am J Neuroradiol 26 (2005) 1439-1445
10. Bonavita S., Di S.F., and Tedeschi G. Proton MRS in neurological disorders. Eur J Radiol 30 (1999) 125-131
11. Gussew A., Rzanny R., Scholle H.C., et al. Quantitation of glutamate in the brain by using MR proton spectroscopy at 1.5 T and 3 T [article in German]. Rofo 180 (2008) 722-732
12. Hammen T., Stefan H., Eberhardt K.E., et al. Clinical applications of 1H-MR spectroscopy in the evaluation of epilepsies-what do pathological spectra stand for with regard to current results and what answers do they give to common clinical questions concerning the treatment of epilepsies?. Acta Neurol Scand 108 (2003) 223-238
13. Hammen T., Kerling F., Schwarz M., et al. Identifying the affected hemisphere by (1)H-MR spectroscopy in patients with temporal lobe epilepsy and no pathological findings in high resolution MRI. Eur J Neurol 13 (2006) 482-490
14. Natt O., Bezkorovaynyy V., Michaelis T., et al. Use of phased array coils for a determination of absolute metabolite concentrations. Magn Reson Med 53 (2005) 3-8
15. Brown M.A. Time-domain combination of MR spectroscopy data acquired using phased-array coils. Magn Reson Med 52 (2004) 1207-1213
16. Baker E.H., Basso G., Barker P.B., et al. Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging 27 (2008) 489-499
17. Pouwels P.J., and Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 39 (1998) 53-60
18. Schuff N., Ezekiel F., Gamst A.C., et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 45 (2001) 899-907
19. Ebel A., and Maudsley A.A. Detection and correction of frequency instabilities for volumetric 1H echo-planar spectroscopic imaging. Magn Reson Med 53 (2005) 465-469
20. Doyle T.J., Bedell B.J., and Narayana P.A. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain. Magn Reson Med 33 (1995) 755-759
21. Lim K.O., and Spielman D.M. Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn Reson Med 37 (1997) 372-377
22. Pfefferbaum A., Adalsteinsson E., Spielman D., et al. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med 41 (1999) 276-284
23. Hetherington H.P., Pan J.W., Mason G.F., et al. Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn Reson Med 36 (1996) 21-29
24. Lundbom N., Barnett A., Bonavita S., et al. MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain. Magn Reson Med 41 (1999) 841-845
25. Noworolski S.M., Nelson S.J., Henry R.G., et al. High spatial resolution 1H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain. Magn Reson Med 41 (1999) 21-29
26. Sailasuta N., Ernst T., and Chang L. Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging 26 (2008) 667-675
27. Chang L., Jiang C.S., and Ernst T. Effects of age and sex on brain glutamate and other metabolites. Magn Reson Imaging 27 (2009) 142-145
28. Pouwels P.J., Brockmann K., Kruse B., et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 46 (1999) 474-485
29. Kreis R., Ernst T., and Ross B.D. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 30 (1993) 424-437
30. Horska A., Kaufmann W.E., Brant L.J., et al. In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging 15 (2002) 137-143
31. Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14 (2001) 260-264
32. Zaaraoui W., Fleysher L., Fleysher R., et al. Human brain-structure resolved T(2) relaxation times of proton metabolites at 3 Tesla. Magn Reson Med 57 (2007) 983-989
33. Hammen T., Stadlbauer A., Tomandl B., et al. Short TE single-voxel 1H-MR spectroscopy of hippocampal structures in healthy adults at 1.5 Tesla-how reproducible are the results?. NMR Biomed 18 (2005) 195-201
34. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30 (1993) 672-679
35. Helms G. A precise and user-independent quantification technique for regional comparison of single volume proton MR spectroscopy of the human brain. NMR Biomed 13 (2000) 398-406
36. Nagae-Poetscher L.M., Bonekamp D., Barker P.B., et al. Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study. J Magn Reson Imaging 19 (2004) 27-33
37. Komoroski R.A., Heimberg C., Cardwell D., et al. Effects of gender and region on proton MRS of normal human brain. Magn Reson Imaging 17 (1999) 427-433
38. Degaonkar M.N., Pomper M.G., and Barker P.B. Quantitative proton magnetic resonance spectroscopic imaging: regional variations in the corpus callosum and cortical gray matter. J Magn Reson Imaging 22 (2005) 175-179
39. Pouwels P.J., and Frahm J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 10 (1997) 73-78
40. Blakely R.D., and Coyle J.T. The neurobiology of N-acetylaspartylglutamate. Int Rev Neurobiol 30 (1988) 39-100
41. Urenjak J., Williams S.R., Gadian D.G., et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13 (1993) 981-989
42. Vermathen P., Laxer K.D., Matson G.B., et al. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging. Radiology 214 (2000) 403-410
43. Mouritzen D.A. The density of neurons in the human hippocampus. Neuropathol Appl Neurobiol 5 (1979) 249-264
44. Babb T.L., Brown W.J., Pretorius J., et al. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia 25 (1984) 729-740
45. Choi C.G., and Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med 41 (1999) 204-207
46. Choi C.G., Ko T.S., Lee H.K., et al. Localized proton MR spectroscopy of the allocortex and isocortex in healthy children. AJNR Am J Neuroradiol 21 (2000) 1354-1358
47. Rockel A.J., Hiorns R.W., and Powell T.P. The basic uniformity in structure of the neocortex. Brain 103 (1980) 221-244
48. Arslanoglu A., Bonekamp D., Barker P.B., et al. Quantitative proton MR spectroscopic imaging of the mesial temporal lobe. J Magn Reson Imaging 20 (2004) 772-778
49. Barker P.B., Szopinski K., and Horska A. Metabolic heterogeneity at the level of the anterior and posterior commissures. Magn Reson Med 43 (2000) 348-354
50. Moffett J.R., Namboodiri M.A., and Neale J.H. Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J Histochem Cytochem 41 (1993) 559-570